Abstract:Exosomal miR‐1290 induces the downregulation of Akt2 expression and activation of the Akt2 downstream signaling pathway to polarize M2 macrophages. A, Localization of MiR1290 in Huh7 cells was visualized by FISH. MiR1290 probes were tagged with FAM (green) and DAPI (blue) was identified as nuclei. B, The TargetScan website was used to predict the binding site of miR‐1290 in the Akt2 3′UTR. A luciferase reporter assay with sea cucumber luciferin as the standardized internal reference was performed after cotransfection of a wild‐type/mutant Akt2 3′UTR and miR‐1290 mimic into 293T cells for 24 h. C and E, The protein expression of Akt2 and the downstream signaling pathway molecule C/EBP‐β in macrophages transfected with the miR‐1290 mimic/inhibitor was measured by Western blotting using GAPDH as the standardized control. D and F, An in vitro Transwell assay detected the effect of macrophages transfected with the miR‐1290 inhibitor in combination with the application of an Akt2 inhibitor on 97H hepatocellular carcinoma cell migration, as well as the morphology of the migrating cells. G, The protein expression of GAPDH (internal control) was measured by Western blotting to detect the effect of miR‐1290‐transfected macrophages treated with an Akt2 inhibitor on EMT protein markers in hepatocellular carcinoma cells; densitometry was also performed. The data are shown as the mean of three independent experiments (*, P < 0.05). Hypoxia plays an important role in the metastasis of hepatocellular carcinoma (HCC). Exosomes have been widely studied as mediators of communication between tumours and immune cells. However, the specific mechanism by which hypoxic HCC cell‐derived exosomes suppress antitumor immunity is unclear. Hypoxia scores were determined for The Cancer Genome‐Liver Hepatocellular Carcinoma (TCGA‐LIHC) dataset patients, and HCC patients in the hyperhypoxic group had a higher degree of M2 macrophage infiltration. Patients in the M2 high‐invasion group had a lower probability of survival than those in the low‐invasion group. In vivo and in vitro experiments demonstrated that exosomes secreted by hypoxic HCC cells promote M2 macrophage polarization. This polarization induces apoptosis in CD8+ T cells. Additionally, it encourages epithelial–mesenchymal transition (EMT), which increases HCC migration. Exosomal miRNA sequencing revealed that miR‐1290 was highly expressed in exosomes secreted by hypoxic HCC cells. Mechanistically, miR‐1290 in macrophages inhibited Akt2 while upregulating PD‐L1 to promote M2 polarization, induce apoptosis in CD8+ T cells, and enhance EMT in HCC. Animal studies found that the miR‐1290 antagomir in combination with the immune checkpoint inhibitor produced better antitumor effects than the monotherapies. In conclusion, the secretion of exosome‐derived miR‐1290 from HCC cells in a hypoxic environment supported immune escape by HCC cells by promoting M2 macrophage polarization to induce apoptosis in CD8+ T cells and enhance EMT that promoted HCC metastasis. Therefore, miR‐1290 is an important molecule in antitumor immunity in HCC, and inhibition of miR‐1290 could provide a novel immunotherapeutic approach for HCC treatment.

Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1

Exosomal Mir-1290 Promotes Angiogenesis in Hepatocellular Carcinoma Via Targeting SMEK1

Exosome-derived Mir-182-5p Promoted Cholangiocarcinoma Progression and Vasculogenesis by Regulating ADK/SEMA5a/PI3K Pathway

Exosomal Mir-183-5p Promotes Angiogenesis in Colorectal Cancer by Regulation of FOXO1

MicroRNA-1296 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting SRPK1-mediated PI3K/AKT Pathway

Exosome Circcmtm3 Promotes Angiogenesis and Tumorigenesis of Hepatocellular Carcinoma Through Mir-3619-5p/sox9

Hepatocellular Carcinoma Cell-Secreted Exosomal MicroRNA-210 Promotes Angiogenesis in Vitro and in Vivo

Exosomal miR-3682-3p Suppresses Angiogenesis by Targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 Pathway in Hepatocellular Carcinoma

Methylation-associated Silencing of Microrna-129-3p Promotes Epithelial-Mesenchymal Transition, Invasion and Metastasis of Hepatocelluar Cancer by Targeting Aurora-A.

Exosomal miR-3174 induced by hypoxia promotes angiogenesis and metastasis of hepatocellular carcinoma by inhibiting HIPK3

Exosomal delivery of miR-200b-3p suppresses the growth of hepatocellular carcinoma cells by targeting ERG- and VEGF-mediated angiogenesis

Circ-0044539 promotes lymph node metastasis of hepatocellular carcinoma through exosomal-miR-29a-3p

Hepatocellular carcinoma cells-derived exosomal microRNA-378b enhances hepatocellular carcinoma angiogenesis

Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma

Gastric cancer cell-derived exosomal miRNA-128-3p promotes angiogenesis by targeting SASH1

Hypoxic tumour‐derived exosomal miR‐1290 exacerbates the suppression of CD8+ T cells by promoting M2 macrophage polarization

Methylation-mediated Repression of Microrna-129-2 Suppresses Cell Aggressiveness by Inhibiting High Mobility Group Box 1 in Human Hepatocellular Carcinoma.

MiR-146a Enhances Angiogenic Activity of Endothelial Cells in Hepatocellular Carcinoma by Promoting PDGFRA Expression.

MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling

Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma

MiR-429 Increases the Metastatic Capability of HCC Via Regulating Classic Wnt Pathway Rather Than Epithelial–mesenchymal Transition